Wednesday, April 8, 2009

Biotech bits take 2

Many of you by now have seen that Genentech is pulling the psoriasis drug Raptiva off the U.S. market. This follows the removal of the drug from the European market in Feb, when fears first emerged that the drug was causing a rare brain disorder, progressive multifocal leukoencephalopathy.

What took the U.S. so long?

If you're on this drug, please call your physician immediately to discuss your treatment.

No comments:

Post a Comment